Recruitment complete

Is perimenopause affecting your quality of life?

Researchers at Clinical Research Australia are investigating whether a probiotic supplement can improve quality of life during perimenopause.

Recruitment for this study is now complete. We are no longer accepting applications. Thank you to everyone who expressed interest.

Interested in future studies?

Perimenopause can feel different for everyone

Are you experiencing changes such as:

✓Changes in mood
✓Poor sleep
✓Low energy or fatigue
✓Difficulty concentrating
✓Hot flushes or night sweats
✓Changes in libido
✓Digestive symptoms
✓Joint discomfort
✓Reduced overall wellbeing

These are among the symptoms investigated in this study.

About the research

A rigorous study of perimenopausal wellbeing

Preliminary research suggests probiotics may help with symptoms experienced during the menopausal transition. This study will investigate whether a probiotic called LactoSpore® can improve menopause-related quality of life, including mood, sleep, energy, concentration, vasomotor symptoms, libido, digestion, joint comfort and overall wellbeing.

Blood markers that may be associated with perimenopausal symptoms will also be measured. This is an ethics-approved, randomised, double-blind, placebo-controlled clinical trial. Half of participants will receive LactoSpore® and half will receive placebo capsules.

What participation involves

Study participation at a glance

01

Apply online

Complete a confidential eligibility questionnaire (5–10 minutes).

02

Telephone interview

A researcher will discuss the study and assess your eligibility (about 10 minutes).

03

Visit our Duncraig clinic

Attend two assessment visits—at baseline and week 12 (about 30 minutes each).

04

Complete two fasting blood tests

Samples are collected at a Western Diagnostics Pathology clinic at baseline and week 12.

05

Take study capsules

Take one probiotic or placebo capsule daily for 12 weeks.

06

Complete online questionnaires

Complete brief questionnaires online at weeks 4 and 8 (about 10 minutes).

Study population

The study eligibility criteria included:

  • You are a woman aged 40–55 years
  • Your menstrual cycle has changed for at least two months
  • Perimenopausal symptoms are affecting your quality of life
  • You are generally healthy and a non-smoker
  • You can attend two appointments in Duncraig
  • You are willing to take one capsule daily for 12 weeks
Ethics approvedNIIM Ethics Committee
Ref. 0164E_2026
Registered trialAustralian & New Zealand
Clinical Trials Registry
Experienced team5,000+ participants
in past studies
ConfidentialVoluntary participation
and protected details

Recruitment update

Recruitment for this study is complete.

We are no longer accepting applications. Thank you to everyone who expressed interest. You can explore our current studies or join the participant community below to hear about future opportunities.

Questions? Call our research team on 08 9448 7376

Future study opportunities

Not seeing the right study today?

Join our participant community and receive occasional emails when new clinical trials begin recruiting.

No obligation to participate. Unsubscribe at any time.